VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ABUS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ABUSArbutus Biopharma Corporation
$4.68$924M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksABUSPrice History

ABUS logoArbutus Biopharma Corporation (ABUS) Stock Price History

Historical prices from 2007 to 2026

$4.68+0.10  (+2.18%)close Jun 29
Returns
1M
+2.6%
3M
+8.8%
YTD
-1.9%
1Y
+51.5%
3Y
+27.8%
5Y
+8.2%
ATH$31.48Mar 2014-85.1%
ATL$0.82Oct 2019pre-split
Avg Vol (50D)1.8M/ day
52-Week Range$3.04 — $5.10
LowCurrent: $4.68High

Loading 10-year price history...

ABUS Historical Performance

1 YearTotal Return
+32.3%
Price: +51.5%
3 YearsTotal Return
+97.3%
CAGR: +25.4%
Price: +108.9%
5 YearsTotal Return
+35.6%
CAGR: +6.3%
Price: +48.6%
YTD
-1.9%

ABUS Annual Returns

Year-by-year price performance · 2007–2026

Best+211.9%2012
Worst-71.6%2008
Up years11/20
2007-27.8%
2008-71.6%
2009+142.1%
2010+2.2%
2011-67.6%
2012+211.9%
2013+57.5%
2014+95.0%
2015-69.9%
2016-45.8%
2017+102.0%
2018-29.7%
2019-30.5%
2020+20.7%
2021+6.9%
2022-41.5%
2023+12.1%
2024+26.3%
2025+46.2%
2026-2.3%
2007 annual price return
-27.8%
2008 annual price return
-71.6%
2009 annual price return
+142.1%
2010 annual price return
+2.2%
2011 annual price return
-67.6%
2012 annual price return
+211.9%
2013 annual price return
+57.5%
2014 annual price return
+95.0%
2015 annual price return
-69.9%
2016 annual price return
-45.8%
2017 annual price return
+102.0%
2018 annual price return
-29.7%
2019 annual price return
-30.5%
2020 annual price return
+20.7%
2021 annual price return
+6.9%
2022 annual price return
-41.5%
2023 annual price return
+12.1%
2024 annual price return
+26.3%
2025 annual price return
+46.2%
2026 annual price return
-2.3%
LessMore
Alpha vs S&P 500
1Y+11.5%
3Y+3.3%
5Y-4.6%

Price returns only.

Download Historical Data

4,762 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

ABUS Stock Price Trajectory (2007–2026)

As of June 30, 2026, Arbutus Biopharma Corporation (ABUS) trades at $4.68, representing a +51.5% return over the past year. The stock has delivered a +35.6% total return over five years (+8.2% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $31.48 on March 13, 2014. From this peak, ABUS has corrected -85.1%, currently trading 6% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers REPL (+20.6% 1Y), ASMB (+48.8% 1Y), and HBIO (+38.0% 1Y), ABUS has outperformed the peer group average. Compare ABUS vs REPL →

ABUS Historical Price Data · from 2007

Rows 1–50 of 4,762
Date Open High Low Close Volume Change %
2026-06-294.624.694.614.682.50M+2.18%
2026-06-264.424.634.394.580+3.85%
2026-06-254.484.504.324.412.69M-1.12%
2026-06-244.464.524.364.462.46M+0.22%
2026-06-234.494.584.394.453.45M-1.55%
2026-06-224.594.794.464.525.25M-0.66%
2026-06-184.534.654.464.553.88M+2.71%
2026-06-174.404.524.364.432.00M+0.91%
2026-06-164.364.394.294.391.10M+1.62%
2026-06-154.304.374.264.321.05M+1.41%
2026-06-124.274.334.254.26942K-0.70%
2026-06-114.124.294.064.291.88M+4.13%
2026-06-104.224.274.094.121.86M-3.06%
2026-06-094.294.364.184.25978K+0.24%
2026-06-084.304.304.214.24670K-0.24%
2026-06-054.324.364.214.251.09M-2.30%
2026-06-044.354.414.254.35715K0.00%
2026-06-034.284.364.214.351.71M+2.11%
2026-06-024.444.474.194.261.74M-4.91%
2026-06-014.464.564.404.48832K-1.75%
2026-05-294.614.704.544.562.20M-0.87%
2026-05-284.624.634.514.601.01M-0.86%
2026-05-274.694.794.614.643.52M0.00%
2026-05-264.364.644.344.642.12M+6.67%
2026-05-224.444.534.334.35829K-2.03%
2026-05-214.324.504.294.442.32M+1.60%
2026-05-204.204.464.204.372.39M+4.05%
2026-05-194.114.204.064.20836K+0.72%
2026-05-184.244.294.134.17895K-1.65%
2026-05-154.304.334.184.241.40M-2.53%
2026-05-144.284.374.244.35901K+0.93%
2026-05-134.494.504.264.311.40M0.00%
2026-05-124.354.354.254.311.02M-1.82%
2026-05-114.384.464.314.39751K+1.15%
2026-05-084.344.404.314.34677K-0.23%
2026-05-074.414.454.284.35920K-1.58%
2026-05-064.454.484.394.421.01M+0.50%
2026-05-054.444.544.354.40263K+0.18%
2026-05-044.294.474.264.39787K+1.62%
2026-05-014.174.334.174.32776K+2.86%
2026-04-304.204.234.134.20761K+1.69%
2026-04-294.104.144.014.131.10M-0.48%
2026-04-284.274.344.094.151.26M-3.04%
2026-04-274.174.334.174.285.04M+1.90%
2026-04-244.294.294.054.207.96M-1.18%
2026-04-234.404.434.154.254.99M-4.06%
2026-04-224.464.484.414.43927K0.00%
2026-04-214.604.634.424.43891K-3.70%
2026-04-204.704.714.594.60858K-2.54%
2026-04-174.684.754.604.721.03M+0.85%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

ABUS — Frequently Asked Questions

Quick answers to the most common questions about buying ABUS stock.

How has ABUS stock performed recently?

ABUS returned +51.5% over the past year, beating its 5-year annualized CAGR of +8.2%. The stock trades above its 200-day moving average, confirming the uptrend.

What is ABUS's all-time high price?

Arbutus Biopharma Corporation reached $31.48 on 2014-03-13. The 52-week high is $5.10. Current 1-year return of +51.5% places the stock closer to historical peaks.

Where can I download ABUS historical price data?

This page provides ABUS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2007-2026, downloadable in CSV format.

478 data points · sampled from 4,762